Related Experiment Videos
Loss of RhoB expression in human lung cancer progression
Julien Mazieres1, Teresita Antonia, Ghislaine Daste
1Institut National de la Santé et de la Recherche Médicale U563, Department of Therapeutic Innovation and Molecular Oncology. Claudius Regaud Institute, Toulouse, France.
Purpose:
RhoB is a low molecular weight GTPase belonging to the Ras protein superfamily. Whereas most Rho proteins have been shown to have a positive role in proliferation and malignant transformation, the specific role of RhoB appears more divergent. We reported previously that RhoB inhibits cell proliferation in various human cancer cells. Here, we studied the specific role played by RhoB in human lung cancer.
Experimental Design:
We analyzed the expression of RhoB protein by immunostaining in human lung tissues ranging from normal to invasive carcinoma from different histological types in two large independent studies of, respectively, 94 and 45 samples. We then studied the cellular effect of RhoB overexpression in a model of lung cancer (A549, adenocarcinoma) and tumorigenicity in nude mice.
Results:
We showed in both studies that RhoB protein was expressed in normal lung and decreased dramatically through lung cancer progression (P < 0.01). Interestingly, RhoB expression was lost in 96% of invasive tumors and reduced by 86% in poorly differentiated tumors compared with the nonneoplastic epithelium. Moreover, the loss of expression of RhoB correlated significantly with tumor stage and proliferative index, whereas no correlation was found between RhoB and p53 or Bcl-2 expression. We then showed that ectopic expression of RhoB in lung cancer cell line A549 suppressed cell proliferation, anchorage-independent growth, and xenograft tumor growth in nude mice.
Conclusions:
RhoB loss of expression occurs very frequently in lung carcinogenesis, reinforcing its putative tumor suppressive activity, and raising the value of its potential use in cancer therapy.
Insights
Loss of RhoB protein expression is frequent in lung cancer, indicating its role as a tumor suppressor. Restoring RhoB may offer a new therapeutic strategy for lung cancer patients.
Area of Science:
- Molecular Biology
- Oncology
- GTPase Signaling
Background:
- RhoB, a member of the Ras superfamily of low molecular weight GTPases, exhibits diverse cellular functions.
- While many Rho proteins promote proliferation and malignancy, RhoB has been previously shown to inhibit cancer cell growth.
Purpose of the Study:
- To investigate the specific role of RhoB in human lung cancer development and progression.
- To determine if RhoB acts as a tumor suppressor in lung carcinogenesis.
Main Methods:
- Immunohistochemical analysis of RhoB protein expression in 139 human lung tissue samples (94 + 45) across normal to invasive carcinoma stages.
- Functional studies involving RhoB overexpression in the A549 lung cancer cell line and assessment of tumorigenicity in nude mice.
Main Results:
- RhoB expression significantly decreased with lung cancer progression, with loss in 96% of invasive tumors and 86% in poorly differentiated tumors.
- Loss of RhoB expression correlated with advanced tumor stage and higher proliferative index.
- Ectopic RhoB expression suppressed lung cancer cell proliferation, anchorage-independent growth, and xenograft tumor formation in vivo.
Conclusions:
- Frequent loss of RhoB expression in lung carcinogenesis supports its role as a tumor suppressor.
- RhoB's tumor-suppressive activity suggests its potential as a therapeutic target for lung cancer treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation